News

Cardiac amyloidosis is a serious heart disease that is often diagnosed too late because its symptoms overlap with those of other cardiovascular diseases. Using…

ABSTRACTBackgroundCardiac amyloidosis, primarily due to immunoglobulin light chain (AL) or transthyretin (ATTR) amyloid, is an increasingly recognized cause of…

Cardiac involvement is the principal determinant of prognosis in light-chain (AL) amyloidosis. B-type natriuretic peptide (BNP) and N-terminal pro-B-type…

Significant gaps remain in diagnosing hereditary transthyretin amyloidosis (hATTR) within the Black population, a new study in the Journal of Community Genetics…

Measuring blood levels of a protein called neurofilament light chain (NfL) may help identify nerve damage in people with hereditary transthyretin amyloidosis with…

DelveInsight's "Cardiac Amyloidosis Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of Cardiac Amyloidosis,…

ROLE SUMMARYThe Medical Engagement, Strategy & Insights Director provides senior scientific and medical expertise in Transthyretin Amyloid Cardiomyopathy (ATTR-…

Scientific Frontline: Extended "At a Glance" Summary: Hereditary ATTR Amyloidosis and Redox ImbalanceThe Core Concept: Hereditary ATTR amyloidosis is a progressive…

AbstractBackgroundVal142Ile hereditary transthyretin amyloidosis (hATTR) is an underrecognized cause of heart failure with preserved ejection fraction (HFpEF) in…

AbstractHereditary transthyretin amyloidosis (ATTRv) is a progressive, life-threatening disease caused by mutations in the TTR gene. It is characterized by marked…